Last updated on September 2017

Study to Evaluate Safety and Efficacy of Three Different Dosages of NewGam in Patients With Chronic Inflammatory Demyelinating Poly (Radiculo) Neuropathy


Brief description of study

Study to evaluate the Efficacy and Safety of Three Different Dosages of NewGam in Patients With Chronic Inflammatory Demyelinating Poly(radiculo)neuropathy

Detailed Study Description

Prospective, Double-blind, Randomized, Multicenter Phase III Study Evaluating Efficacy and Safety of Three Different Dosages of NewGam in Patients With Chronic Inflammatory Demyelinating Poly(radiculo)neuropathy ("ProCID trial")

Clinical Study Identifier: NCT02638207

Contact Investigators or Research Sites near you

Start Over

Mikaela Grupp

Austin Health
Heidelberg, Australia
  Connect »

Mikaela Grupp

Royal Melbourne Hosptial
Parkville, Australia
  Connect »

Mikaela Grupp

Toronto General Hospital
Toronto, ON Canada
  Connect »

Mikaela Grupp

University Hospital Brno
Brno, Czechia
  Connect »

Mikaela Grupp

Outpatient Clinic of Neurology
Hradec Králové, Czechia
  Connect »

Mikaela Grupp

Faculty Hospital Hradec Kralove
Hradec Králové, Czechia
  Connect »

Mikaela Grupp

Regional Hospital Pardubice
Pardubice, Czechia
  Connect »

Mikaela Grupp

Thomayer Faculty Hospital
Prague, Czechia
  Connect »

Mikaela Grupp

University Medical Center Goettingen
Goettingen, Germany
  Connect »

Mikaela Grupp

University Hospital of Leipzig
Leipzig, Germany
  Connect »

Mikaela Grupp

Pesci Tudomanyegyetem Klinikai Kozpont
Pécs, Hungary
  Connect »

Mikaela Grupp

Szegedi Tudom nyegyetem OK Neurol giai Klinika
Szeged, Hungary
  Connect »

Mikaela Grupp

Wojewodzki Szpital Specjalistyczny W Olsztynie
Olsztyn, Poland
  Connect »